Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Australia Pharmacists Tighten Allowable Sales Of Painkillers

This article was originally published in PharmAsia News

Executive Summary

Australian pharmacists have adopted a policy of screening customers who seek to buy painkillers containing addictive ingredients such as codeine. The Pharmacy Guild of Australia and the Australian Self-Medication Industry announced the checks as part of an effort to deal with abuse of the medicines, primarily Nurofen Plus and Panadeine Plus. Pharmacists are to counsel customers before they buy the drugs and limit purchases of no more than a five-day supply. The Therapeutic Goods Administration plans to seek public comment before putting the changes into regulations. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts